Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$6.35M Buy
13,878
+6,056
+77% +$2.98M 7.83% 8
2023
Q3
$3.81M Sell
7,822
-5,508
-41% -$2.59M 4.96% 15
2023
Q2
$5.96M Buy
13,330
+3,987
+43% +$2.01M 6.95% 6
2023
Q1
$4.54M Sell
9,343
-1,688
-15% -$834K 4.95% 15
2022
Q4
$5.65M Buy
11,031
+1,070
+11% +$562K 5.33% 11
2022
Q3
$4.83M Sell
9,961
-963
-9% -$468K 4.63% 6
2022
Q2
$5.11M Buy
10,924
+1,738
+19% +$773K 4.64% 8
2022
Q1
$4M Sell
9,186
-1,405
-13% -$588K 3.52% 17
2021
Q4
$4.91M Buy
+10,591
New +$4.69M 3.73% 17

Other funds holding HUM

Pavadi Capital's HUM Position: Q4 2023 in Review

Pavadi Capital increased its Humana (HUM) stake by 77% in Q4 2023, buying an estimated $2.98M and bringing the position to 13,878 shares worth $6.35M. The position accounts for 7.83% of the portfolio, ranked #8.

Pavadi Capital first reported a position in HUM in Q4 2021 and has held it in 9 quarters since. 1,153 funds tracked by Wall St. Rank hold HUM as of Q4 2023.

  • Pavadi Capital held 13,878 shares of Humana worth $6.35M as of Q4 2023.
  • Pavadi Capital bought 6,056 Humana shares in Q4 2023, an estimated $2.98M.
  • Humana made up 7.83% of Pavadi Capital's portfolio in Q4 2023, its #8 holding.
  • Pavadi Capital first reported a position in Humana in Q4 2021 and has held it in 9 quarters since.
  • 1,153 funds tracked by Wall St. Rank held Humana as of Q4 2023.

Based on Pavadi Capital's 13F filing for Q4 2023, filed 14 Feb 2024.